These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 38215)

  • 21. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 24. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK; Schrems W
    Fortschr Ophthalmol; 1984; 81(2):127-9. PubMed ID: 6145665
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of beta-adrenergic blockade in coronary artery surgery: clinical research.
    Yorulmaz FM; Kuralay E; Tatar H; Süer H; Oztürk OY
    Cardiovasc Surg; 1993 Aug; 1(4):410-3. PubMed ID: 7915625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metipranolol and propranolol: no CNS effects of a single oral dose.
    Levander S; Gillner A
    Psychopharmacology (Berl); 1982; 76(4):359-66. PubMed ID: 6126894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
    Herbaczyńska-Cedro K; Woźniewicz B; Broniszewska-Ardelt B; Ceremuzyński L
    Cardiology; 1981; 67(4):206-18. PubMed ID: 6113891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long term effects of the beta-adrenergic blocking agent atenolol (Tenormin) on coronary heart disease: a study of 125 patients (author's transl)].
    Langbehn AF; Burmeister G; Horst H; Sonntag F; Klempien EJ
    Med Klin; 1978 Jan; 73(3):101-5. PubMed ID: 622059
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy with beta-blocking-agents (author's transl)].
    Bolte HD
    MMW Munch Med Wochenschr; 1978 Nov; 120(44):1461-6. PubMed ID: 30043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of beta adrenergic blocking agents on erythropoiesis in rats.
    Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
    J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exercise test with beta receptor blockade in healthy subjects and in patients with ischemic heart disease].
    Janota M; Fabián J; Rohác J; Vrána M
    Cas Lek Cesk; 1978 Jul; 117(28):865-9. PubMed ID: 28848
    [No Abstract]   [Full Text] [Related]  

  • 36. Study of the metabolic effects of bunitrolol (Koe 1366) in angina induced by catecholamine infusion.
    Cuccurullo F; Masi M; Mezzetti A; Rosini R; Luciani G; Tomassetti V; Abate G; Lenzi S
    Arzneimittelforschung; 1979; 29(1):138-41. PubMed ID: 36102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of beta-blockers on the activity of nonspecific phosphomonoesterases in the central nervous system of guinea pigs].
    Turecký L; Krizko J
    Bratisl Lek Listy; 1983; 79(4):402-10. PubMed ID: 6134573
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanism of action of the new beta-adrenolytic drug VUL 111 upon the cardiovascular system. 1. Beta-adrenolytic activity on peroral administration and ways of metabolic degradation (author's transl)].
    Drimal J; Strízová K; Borovicová F; Gibala P; Stefek M; Kovácik V
    Bratisl Lek Listy; 1978 Jul; 70(1):11-28. PubMed ID: 28818
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardioprotective effect of metipranolol on ischemic heart muscle.
    Gvozdják J; Gvozdjáková A; Kucharská J; Bada V
    Cardiology; 1989; 76(3):206-10. PubMed ID: 2570631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.